mCRC

11 registered clinical trials studyying mCRC — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	A Clinical Study of Iparomlimab and Tuvonralimab Combined With Fruquintinib and Heterogeneous Radiotherapy Ver NCT07502014	Huazhong University of Science and Technology	Phase 2
Not Yet Recruiting	FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Micros NCT07446322	Oncolytics Biotech	Phase 2
Not Yet Recruiting	MA-CRC-II-016 SHR-1811 NCT07355764	Peking Union Medical College Hospital	Phase 2
Not Yet Recruiting	Radiotherapy Combined QL1706, TAS-102 and Bevacizumab in mCRC NCT07116577	Jinan Central Hospital	Phase 2
Withdrawn	Tislelizumab Combined With Fruquintinib for Metastatic pMMR/MSS Colorectal Cancer NCT05690035	Sun Yat-sen University	Phase 2
Active Not Recruiting	Phase I PK Comparison of HLX05 vs. Erbitux® in Healthy Chinese Males: Safety, Immunogenicity, and Pharmacokine NCT06980454	Shanghai Henlius Biotech	Phase 1
Recruiting	"Thymalfasin Immunotherapy Study with Triple Regimen in Advanced MSS/pMMR Colorectal Cancer" NCT06829355	Beijing Friendship Hospital	Phase 2
Unknown	The Efficacy and Safety of HLX208 in Metastatic Colorectal Cancer (mCRC) With BRAF V600E Mutation NCT05127759	Shanghai Henlius Biotech	Phase 2
Terminated	QUILT 3.071: NANT Colorectal Cancer (CRC) Vaccine NCT03563157	ImmunityBio, Inc.	Phase 1 / Phase 2
Unknown	Evaluate the Efficacy of Irinotecan Versus Oxaliplatin in the First-line Treatment of Refractory Metastatic Co NCT03567629	Peking University	Phase 2
Completed	LifePearl-Iri Pharmacokinetic Study NCT02547480	Terumo Europe N.V.	N/A